125 related articles for article (PubMed ID: 22820712)
1. Preexposure prophylaxis for HIV infection.
Steinbrook R
JAMA; 2012 Sep; 308(9):865-6. PubMed ID: 22820712
[No Abstract] [Full Text] [Related]
2. Ethical challenges of preexposure prophylaxis for HIV.
Jay JS; Gostin LO
JAMA; 2012 Sep; 308(9):867-8. PubMed ID: 22847147
[No Abstract] [Full Text] [Related]
3. FDA paves the way for pre-exposure HIV prophylaxis.
Holmes D
Lancet; 2012 Jul; 380(9839):325. PubMed ID: 22852138
[No Abstract] [Full Text] [Related]
4. Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
Blackwell CW
Nurse Pract; 2014 Sep; 39(9):50-3. PubMed ID: 25140852
[TBL] [Abstract][Full Text] [Related]
5. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.
Burns DN; Grossman C; Turpin J; Elharrar V; Veronese F
Curr HIV/AIDS Rep; 2014 Dec; 11(4):393-403. PubMed ID: 25283184
[TBL] [Abstract][Full Text] [Related]
6. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
[TBL] [Abstract][Full Text] [Related]
7. [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
Marcus U
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():42-4. PubMed ID: 23961656
[No Abstract] [Full Text] [Related]
8. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
Coutinho B; Prasad R
Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
[No Abstract] [Full Text] [Related]
9. Infectious diseases. Doubts dispelled about HIV prevention.
Cohen J
Science; 2015 Mar; 347(6226):1055-6. PubMed ID: 25745140
[No Abstract] [Full Text] [Related]
10. How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention.
Haire B; Kaldor J; Jordens CF
Am J Bioeth; 2012; 12(6):21-30. PubMed ID: 22650457
[TBL] [Abstract][Full Text] [Related]
11. Recent FDA approvals and changes.
AIDS Patient Care STDS; 2010 Feb; 24(2):133-4. PubMed ID: 20156092
[No Abstract] [Full Text] [Related]
12. Still a long wait for approved HIV-protective gel.
Bateman C
S Afr Med J; 2010 Sep; 100(9):560, 562. PubMed ID: 20822637
[No Abstract] [Full Text] [Related]
13. Emtricitabine + tenofovir to prevent HIV transmission. More evaluation needed.
Prescrire Int; 2013 Jul; 22(140):178-81. PubMed ID: 23951592
[TBL] [Abstract][Full Text] [Related]
14. [HIV prophylaxis kits. A concept for emergency treatment in the context of postexposure prophylaxis].
Wicker S; Walcher F; Wutzler S; Marzi I; Stephan C
Chirurg; 2014 Jan; 85(1):60-2. PubMed ID: 24292193
[TBL] [Abstract][Full Text] [Related]
15. HIV study yields unexpected preliminary efficacy results.
Traynor K
Am J Health Syst Pharm; 2008 Apr; 65(8):686-8. PubMed ID: 18387889
[No Abstract] [Full Text] [Related]
16. Study halted: no benefit seen from antiretroviral pill in preventing HIV in women.
Stephenson J
JAMA; 2011 May; 305(19):1952. PubMed ID: 21586708
[No Abstract] [Full Text] [Related]
17. The Truvada wars.
Belluz J
BMJ; 2014 Jun; 348():g3811. PubMed ID: 24961949
[No Abstract] [Full Text] [Related]
18. Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.
Sachdev DD; Stojanovski K; Liu AY; Buchbinder SP; Macalino GE
Clin Infect Dis; 2014 Jun; 58(12):1786-7. PubMed ID: 24729556
[No Abstract] [Full Text] [Related]
19. AIDS research. FDA panel recommends anti-HIV drug for prevention.
Cohen J
Science; 2012 May; 336(6083):792. PubMed ID: 22605725
[No Abstract] [Full Text] [Related]
20. Truvada for HIV prophylaxis in heterosexual patients.
DeDea L
JAAPA; 2012 Oct; 25(10):14. PubMed ID: 23115862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
